Perlara
Perlara, PBC is precision drug discovery that leaves no mutation behind.
Launch date
Employees
Market cap
-
Enterprise valuation
€15—23m (Dealroom.co estimates Aug 2017.)
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$2.5m | Seed | ||
| N/A | $2.2m | Seed | |
| N/A | $2.5m | Seed | |
$120k | Seed | ||
| N/A | N/A | Series A | |
| N/A | $4.1m | Series A | |
| Total Funding | €10.4m | ||
Related Content
Recent News about Perlara
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.